cysteine has been researched along with technetium in 54 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (12.96) | 18.7374 |
1990's | 14 (25.93) | 18.2507 |
2000's | 16 (29.63) | 29.6817 |
2010's | 15 (27.78) | 24.3611 |
2020's | 2 (3.70) | 2.80 |
Authors | Studies |
---|---|
Bassano, D; Foster, AB; Gagne, G; Grossman, ZD; Markarian, B; McAfee, JG; Richardson, R; Subramanian, G | 1 |
Johannsen, B; Münze, R; Spies, H; Syhre, R | 1 |
Ikeda, I; Machida, T; Miki, M; Tanaka, A; Ueda, M | 1 |
Goldsmith, SJ; Hellman, RS; Mena, I; Morgan, RA; Picard, M; Stabin, MG; Stritzke, P; Tikofsky, RS; Vallabhajosula, S; Zimmerman, RE | 1 |
Bowen, BM; Henderson, DR; Kellam, JE; Wood, DE | 1 |
Goto, R; Takeda, A; Tamemasa, O | 1 |
Karube, Y; Kono, A; Maeda, T; Matsushima, Y; Ohya, M; Sugata, S | 1 |
Adams, GP; George, AJ; Heelan, BT; Houston, LL; Jamar, F; McCartney, JE; Oppermann, H; Peters, AM; Tai, MS; Weiner, LM | 1 |
Fogarasi, M; Hnatowich, DJ; Rusckowski, M; Virzi, F; Winnard, P | 1 |
Iznaga Escobar, N; Morales, A; Núñez, G | 1 |
Fogarasi, M; Hnatowich, DJ; Rusckowski, M; Virzi, E; Winnard, P | 1 |
Chang, F; Hnatowich, DJ; Lei, K; Mardirossian, G; Qu, T; Rusckowski, M | 1 |
Noujaim, AA; Sykes, TR; Wang, XB; Woo, TK; Xue, LY | 1 |
Amin, KC; Go, RT; Saha, GB | 1 |
Bogdanov, A; Marecos, E; Petherick, P; Weissleder, R | 1 |
Aguiar Cabeza, E; Hernández Romero, O; Oliva González, J; Pérez Tenorio, G; Pimentel González, G; Quesada Cepero, W; Rebustillo Sierra, M; Sánchez Monzón, I | 1 |
Chiotellis, E; Maina, T; Nock, BA; Papadopoulos, MS; Pirmettis, IC; Raptopoulou, C; Terzis, A; Tsoukalas, C | 1 |
Banerjee, S; Jurisson, S; Kothari, K; Pillai, MR; Samuel, G; Sarma, HD; Suresh, M | 1 |
Ilgan, S; Kim, EE; Liu, CW; Oh, CS; Podoloff, DA; Tansey, W; Yang, DJ; Yu, DF; Zareneyrizi, F | 1 |
Alberto, R; Higginbotham, C; Katti, KV; Schibli, R; Volkert, WA | 1 |
Du, J; Hiltunen, J; Holmberg, AR; Marquez, M; Nilsson, S | 1 |
Carderón, C; Felipe, Y; Freyre, FM; Gavilondo, JV; Oliva, JP; Pimentel, GJ; Quesada, W; Vázquez, JE | 1 |
Arif, M; Mushtaq, AM; Pervez, S | 1 |
Abbruzzes, J; Azhdarinia, A; Bryant, JL; Fogler, WE; Herbst, R; Kalimi, SK; Kim, EE; Kim, KD; Ozaki, K; Podoloff, DA; Roach, JS; Schechter, NR; Wu, P; Yang, DJ; Yu, DF | 1 |
Ang, KK; Azhdarinia, A; Bryant, J; Forster, KM; Hu, M; Kim, EE; Kohanim, S; Oh, CS; Podoloff, DA; Schechter, NR; Wendt, R; Yang, DJ; Yu, DF | 1 |
Frier, M; Paolino, A; Savio, E; Terán, M | 1 |
Bolzati, C; Cavazza-Ceccato, M; Marotta, E; Porchia, M; Refosco, F; Tisato, F; Tomasin, P; Traldi, P; Tubaro, M | 1 |
Murthy, RS; Reddy, LH; Sharma, RK | 1 |
Imam, SK | 1 |
Batista, JF; Perez, MA; Pintado, AP; Quian, YP | 1 |
Aydin, M; Ercan, MT; Gülaldi, NC; Hasçelik, Z; Peksoy, I; Unsal, S; Uysal, U | 1 |
Decristoforo, C; Dietrich, H; Gabriel, M; Skvortsova, I; Virgolini, IJ; von Guggenberg, E | 1 |
Agostini, S; Bandoli, G; Bolzati, C; Caporale, A; Carta, D; Cavazza-Ceccato, M; Refosco, F; Schievano, E; Tisato, F | 1 |
Fujioka, T; Konno, S; Kurihara, T; Murata, M; Nakazora, H; Nemoto, H; Nomoto, N; Sugimoto, H; Toda, T; Wakata, N; Yoshii, Y | 1 |
Adam, MJ; Barta, CA; Bowen, ML; Ewart, CB; Ferreira, CL; Lim, NC; Orvig, C | 1 |
Backer, JM; Backer, M; Blankenberg, FG; Levashova, Z | 1 |
Fuks, L; Gniazdowska, E; Kozminski, P; Lyczko, M; Mieczkowski, J; Narbutt, J | 1 |
Angelo, LS; Gong, J; Kohanim, S; Kurzrock, R; Yang, DJ | 1 |
Borghesani, PR; Borson, S; DeMers, SM; Lewis, DH; Manchanda, V; Pruthi, S | 1 |
Chuttani, K; Kakkar, D; Kaul, A; Mishra, AK; Singh, H; Tiwari, AK | 1 |
Häfeli, UO; Misri, R; Saatchi, K | 1 |
da Silva, NG; de Oliveira Filho, RS; Martinelli, JR; Núñez, EG; Teodoro, R; Wiecek, DP | 1 |
Altai, M; Hosseinimehr, SJ; Orlova, A; Rosestedt, M; Ståhl, S; Tolmachev, V; Wållberg, H | 1 |
Chiotellis, A; Papadopoulos, M; Pelecanou, M; Pirmettis, I; Tsoukalas, C | 1 |
Chakravarty, R; Dash, A; Pillai, MR; Ram, R | 1 |
Barnes, CL; Benny, PD; Cheng, Z; Jiang, H; Kasten, BB; Liu, H; Liu, Y; Qi, S; Tian, M; Zhang, H | 1 |
Afshan, A; Khalid, MA; Saeed, S; Sohaib, M; Yousuf, M | 1 |
Kong, F; Larson, R; Sims-Mourtada, J; Smith, D; Woodward, WA; Yang, D | 1 |
Branco de Barros, AL; Cardoso, VN; de Andrade, AS; dos Santos, SR; Fernandes, SO; Rodrigues Corrêa, C; Serakides, R | 1 |
Al Jammaz, I; Okarvi, SM | 1 |
Altai, M; Andersson, KG; Garousi, J; Löfblom, J; Mitran, B; Orlova, A; Oroujeni, M; Steinhardt, X; Tolmachev, V; Vorobyeva, A | 1 |
Aeron, R; Agarwal, S; Goel, A; Kumar, M; Kumar, V; Sankhwar, S; Singh, M; Yadav, R | 1 |
Bolzati, C; Brunello, S; Forrer, D; Ghiani, S; Maiocchi, A; Salvarese, N; Spolaore, B; Vittadini, A | 1 |
Chiotellis, A; Kiritsis, C; Makrypidi, K; Papadopoulos, M; Paravatou-Petsotas, M; Pelecanou, M; Pirmettis, I; Roupa, I; Shegani, A; Triantopoulou, S | 1 |
1 review(s) available for cysteine and technetium
Article | Year |
---|---|
Molecular nuclear imaging: the radiopharmaceuticals (review).
Topics: Animals; Annexins; Antibodies, Monoclonal; Antigens; Apoptosis; Cysteine; Diagnostic Imaging; DNA; Fluorodeoxyglucose F18; Glycolysis; Humans; Indium Radioisotopes; Ligands; Lymphoma; Myocardial Infarction; Neoplasms; Octreotide; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Technetium; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2005 |
53 other study(ies) available for cysteine and technetium
Article | Year |
---|---|
Myocardial uptake (rabbit) of six 99mTc-tagged pharmaceuticals and 85Sr after vasopressin-induced necrosis.
Topics: Animals; Citrates; Cysteine; Diphosphates; Diphosphonates; Disease Models, Animal; Myocardial Infarction; Rabbits; Radionuclide Imaging; Strontium Radioisotopes; Sugar Acids; Technetium; Vasopressins | 1977 |
Chemical and biological characterization of different Tc complexes of cysteine and cysteine derivatives.
Topics: Acetylcysteine; Animals; Cysteine; Isotope Labeling; Male; Penicillamine; Rats; Technetium; Tissue Distribution | 1978 |
Basic studies of various 99mTc-labelled renal agents and clinical application of 99mTc-malate.
Topics: Acetazolamide; Animals; Cysteine; Female; Gluconates; Humans; Isotope Labeling; Kidney Diseases; Kinetics; Malates; Male; Mice; Rabbits; Radionuclide Imaging; Technetium | 1977 |
Technetium-99m ECD: a new brain imaging agent: in vivo kinetics and biodistribution studies in normal human subjects.
Topics: Adult; Brain; Cysteine; Female; Humans; Male; Middle Aged; Organometallic Compounds; Organotechnetium Compounds; Radiation Dosage; Reference Values; Technetium; Time Factors; Tissue Distribution; Tomography, Emission-Computed; Whole-Body Counting | 1989 |
Technetium-99m cysteine--an agent for renal scintigraphy.
Topics: Animals; Brain; Cysteine; Humans; Injections, Intravenous; Kidney; Liver; Lung; Methods; Pancreas; Radioisotope Renography; Rats; Spleen; Technetium; Urinary Bladder | 1972 |
Tumor detection with some 99mTc-labeled S-containing amino acids.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cysteine; Homocysteine; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Radionuclide Imaging; Technetium; Tissue Distribution | 1984 |
Evaluation of 99mTc labeled amino acids as radiopharmaceuticals IV. S-Substituted cysteines and N-substituted iminodiacetic acids.
Topics: Animals; Cricetinae; Cysteine; Dogs; Imino Acids; Male; Mesocricetus; Pancreas; Radionuclide Imaging; Technetium; Tissue Distribution | 1982 |
Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide.
Topics: Amino Acid Sequence; Animals; Chelating Agents; Cloning, Molecular; Cysteine; Immunoglobulin Fragments; Kinetics; Male; Mice; Mice, SCID; Molecular Sequence Data; Neoplasms, Experimental; Peptides; Protein Folding; Radionuclide Imaging; Rats; Recombinant Fusion Proteins; Technetium; Tissue Distribution | 1995 |
Investigations of ascorbate for direct labeling of antibodies with technetium-99m.
Topics: Antibodies; Ascorbic Acid; Cysteine; Dithionite; Immunoglobulin G; Immunoglobulins, Intravenous; Sulfhydryl Compounds; Technetium | 1994 |
Micromethod for quantification of SH groups generated after reduction of monoclonal antibodies.
Topics: Animals; Antibodies, Monoclonal; Carcinoembryonic Antigen; Cysteine; Disulfides; ErbB Receptors; Humans; Mercaptoethanol; Mice; Microchemistry; Molybdenum; Oxidation-Reduction; Radioimmunodetection; Radioisotopes; Sulfhydryl Compounds; Technetium | 1996 |
Investigations of directly labeling antibodies with rhenium-188.
Topics: Animals; Antibodies; Chelating Agents; Cysteine; Immunoconjugates; Immunoglobulin G; Male; Mercaptoethanol; Metabolic Clearance Rate; Mice; Oxidation-Reduction; Radioisotopes; Rhenium; Sugar Acids; Technetium; Time Factors; Tin; Tissue Distribution | 1996 |
Technetium-99m antibodies labeled with MAG3 and SHNH: an in vitro and animal in vivo comparison.
Topics: Animals; Cross-Linking Reagents; Cysteine; Drug Stability; Immunoglobulin G; Male; Mice; Mice, Inbred Strains; Niacinamide; Succinimides; Technetium; Technetium Tc 99m Mertiatide; Tissue Distribution | 1996 |
Role of transchelation in the uptake of 99mTc-MAb in liver and kidney.
Topics: Animals; Antibodies, Monoclonal; Chelating Agents; Cysteine; Dose-Response Relationship, Drug; Glutathione; Kidney; Liver; Male; Metallothionein; Mice; Mice, Inbred BALB C; Technetium; Time Factors; Tissue Distribution | 1997 |
A rapid chromatographic method for quality control of technetium-99m-bicisate.
Topics: Acetates; Chromatography, Paper; Cysteine; Organotechnetium Compounds; Oxides; Paper; Quality Control; Radiochemistry; Radiopharmaceuticals; Sodium Pertechnetate Tc 99m; Solvents; Technetium; Technetium Compounds; Time Factors | 1997 |
In vivo localization of diglycylcysteine-bearing synthetic peptides by nuclear imaging of oxotechnetate transchelation.
Topics: Animals; Binding Sites; Chelating Agents; Cysteine; Female; Glutamic Acid; Peptides; Protein Binding; Rats; Rats, Inbred F344; Technetium | 1997 |
[Radiolabeling of a new agent for the study of colorectal tumors].
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Blood Proteins; Colorectal Neoplasms; Cysteine; Drug Stability; Humans; Immunoconjugates; Kidney; Male; Mercaptoethanol; Mice; Mice, Inbred BALB C; Oxidation-Reduction; Radioimmunodetection; Radiopharmaceuticals; Reducing Agents; Technetium; Tissue Distribution | 1998 |
Characterization and preliminary evaluation of ester-modified technetium-99m SNS/S mixed ligand complexes as potential brain perfusion agents.
Topics: Animals; Brain; Crystallography, X-Ray; Cysteine; Esters; Ligands; Male; Mice; Organotechnetium Compounds; Perfusion; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium; Technetium Tc 99m Sulfur Colloid; Tin Compounds; Tissue Distribution | 1999 |
Radiochemical studies of 99mTc complexes of modified cysteine ligands and bifunctional chelating agents.
Topics: Animals; Chelating Agents; Chromatography, High Pressure Liquid; Cysteine; Kinetics; Ligands; Male; Mice; Molecular Structure; Technetium; Tissue Distribution | 1999 |
Synthesis of [99mTc]ethylenedicysteine-colchicine for evaluation of antiangiogenic effect.
Topics: Angiogenesis Inhibitors; Animals; Colchicine; Cysteine; Drug Stability; Female; Mammary Neoplasms, Experimental; Rabbits; Radionuclide Imaging; Rats; Rats, Inbred F344; Technetium | 1999 |
In vitro and in vivo evaluation of bidentate, water-soluble phosphine ligands as anchor groups for the organometallic fac-[99mTc(CO)3]+-core.
Topics: Animals; Cysteine; Histidine; Humans; Indicators and Reagents; Metabolic Clearance Rate; Mice; Molecular Structure; Organotechnetium Compounds; Radiopharmaceuticals; Serum Albumin; Technetium; Tissue Distribution | 1999 |
Technetium-99m labelling of glycosylated somatostatin-14.
Topics: Chromatography, High Pressure Liquid; Cysteine; Dextrans; Glycosylation; Half-Life; Histidine; Hydrogen-Ion Concentration; Isotope Labeling; Somatostatin; Technetium | 2001 |
Hexa-histidine tag as a novel alternative for one-step direct labelling of a single-chain Fv antibody fragment with 99m Tc.
Topics: Animals; Antibodies, Monoclonal; Carcinoembryonic Antigen; Chromatography, Gel; Chromatography, Thin Layer; Cysteine; Histidine; Immunoglobulin Variable Region; Isotope Labeling; Male; Mice; Mice, Inbred Strains; Peptide Fragments; Quality Control; Radiopharmaceuticals; Recombinant Proteins; Technetium; Tissue Distribution | 2001 |
Technetium-99m direct radiolabeling of lanreotide: a somatostatin analog.
Topics: Chromatography, High Pressure Liquid; Cysteine; Humans; Peptides, Cyclic; Radiopharmaceuticals; Somatostatin; Technetium | 2001 |
Assessment of antiangiogenic effect using 99mTc-EC-endostatin.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Collagen; Cysteine; Endostatins; Endothelial Growth Factors; Female; Fibroblast Growth Factor 2; In Situ Nick-End Labeling; Intercellular Signaling Peptides and Proteins; Interleukin-8; Lymphokines; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; Paclitaxel; Peptide Fragments; Radionuclide Imaging; Rats; Rats, Inbred F344; Technetium; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Assessment of epidermal growth factor receptor with 99mTc-ethylenedicysteine-C225 monoclonal antibody.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Cell Line; Cetuximab; Cysteine; ErbB Receptors; Female; Humans; Mice; Mice, Nude; Rats; Technetium; Tissue Distribution | 2003 |
Usage of radiopharmaceuticals in the development of pharmaceutical drug delivery systems: validation of [99mTc]DTPA and [99mTc]ECD.
Topics: Cysteine; Drug Delivery Systems; Pentetic Acid; Radiopharmaceuticals; Solubility; Technetium | 2004 |
Electrospray mass spectrometry of a series of mixed nitrido 99gTc- heterocomplexes conjugated with bioactive molecules.
Topics: Biotin; Cysteine; Nitrogen Compounds; Piperazine; Piperazines; Radioisotopes; Spectrometry, Mass, Electrospray Ionization; Technetium; Technetium Compounds | 2004 |
Enhanced tumour uptake of doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles in mice bearing Dalton's lymphoma tumour.
Topics: Animals; Antibiotics, Antineoplastic; Chelating Agents; Cyanoacrylates; Cysteine; Doxorubicin; Drug Compounding; Drug Delivery Systems; Enbucrilate; Excipients; Gamma Cameras; Lymphoma; Mice; Mice, Inbred BALB C; Microspheres; Neoplasm Transplantation; Particle Size; Pentetic Acid; Polymers; Technetium; Tissue Distribution | 2004 |
Scintigraphic images of breast cancer with Tc-99m cysteine.
Topics: Adult; Breast Neoplasms; Cysteine; Female; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium | 2006 |
Accumulation of 99mTc-Cysteine in experimental inflammatory lesions in comparison to 99mTc-glutamine and 99mTc-HIG.
Topics: Animals; Arthritis, Experimental; Cysteine; Disease Models, Animal; Glutamine; Immunoglobulins; Inflammation; Knee Joint; Mice; Organotechnetium Compounds; Radionuclide Imaging; Technetium | 1997 |
99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours.
Topics: Animals; Carcinoma, Medullary; Cysteine; Edetic Acid; Gastrins; Gene Expression Regulation, Neoplastic; Glycine; Humans; Kidney; Liver; Neoplasms; Organotechnetium Compounds; Radionuclide Imaging; Rats; Receptor, Cholecystokinin B; Technetium; Thyroid Neoplasms; Tissue Distribution | 2007 |
Avidin-biotin system: a small library of cysteine biotinylated derivatives designed for the [99mTc(N)(PNP)]2+ metal fragment.
Topics: Animals; Avidin; Biotin; Biotinylation; Cysteine; Drug Design; Drug Stability; Humans; Male; Metabolic Clearance Rate; Metals; Mice; Mice, Inbred BALB C; Organ Specificity; Peptide Library; Radiopharmaceuticals; Rats; Technetium; Tissue Distribution | 2007 |
Familial Creutzfeldt-Jakob Disease with a codon 200 mutation presenting as thalamic syndrome: diagnosis by single photon emission computed tomography using (99m)Tc-ethyl cysteinate dimer.
Topics: Codon; Creutzfeldt-Jakob Syndrome; Cysteine; Female; Humans; Middle Aged; Mutation; Radiopharmaceuticals; Syndrome; Technetium; Thalamic Diseases; Tomography, Emission-Computed, Single-Photon | 2008 |
Pyridine-tert-nitrogen-phenol ligands: N,N,O-Type tripodal chelates for the [M(CO)3]+ core (M = Re, Tc).
Topics: Binding Sites; Chelating Agents; Crystallography, X-Ray; Cysteine; Dimerization; Histidine; Isotope Labeling; Ligands; Magnetic Resonance Spectroscopy; Models, Chemical; Nitrogen; Organometallic Compounds; Oxygen; Phenol; Pyridines; Radiopharmaceuticals; Rhenium; Technetium; Time Factors | 2008 |
Direct site-specific labeling of the Cys-tag moiety in scVEGF with technetium 99m.
Topics: Animals; Binding Sites; Cysteine; Disease Models, Animal; Female; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neovascularization, Pathologic; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Staining and Labeling; Technetium; Tissue Distribution; Vascular Endothelial Growth Factor A | 2008 |
'2+1' Tricarbonyltechnetium(I) and -rhenium(I) mixed-ligand complexes with N-methylpyridine-2-carboxyamide and isocyanide or imidazole ligands-potential precursors of radiopharmaceuticals.
Topics: Animals; Chromatography, High Pressure Liquid; Cysteine; Drug Stability; Histidine; Imidazoles; Isocyanates; Ligands; Nicotinic Acids; Organometallic Compounds; Organotechnetium Compounds; Propionates; Radioisotopes; Radiopharmaceuticals; Rats; Rhenium; Technetium | 2010 |
Molecular imaging of gefitinib activity in an epidermal growth factor receptor (EGFR)-bearing xenograft model.
Topics: Animals; Apoptosis; Blotting, Western; Cell Line, Tumor; Cysteine; ErbB Receptors; Female; Flow Cytometry; Gefitinib; Humans; Immunoprecipitation; Indium Radioisotopes; Mice; Mice, Nude; Molecular Imaging; Neoplasms, Glandular and Epithelial; Phosphorylation; Protein Kinase Inhibitors; Quinazolines; Radionuclide Imaging; Technetium; Tissue Distribution; Xenograft Model Antitumor Assays | 2009 |
Neuroimaging in the clinical diagnosis of dementia: observations from a memory disorders clinic.
Topics: Aged; Brain; Cerebrovascular Disorders; Cognition Disorders; Cysteine; Dementia; Humans; Lewy Bodies; Magnetic Resonance Imaging; Oximes; Radiopharmaceuticals; Retrospective Studies; Technetium; Tomography, Emission-Computed, Single-Photon | 2010 |
Comparative evaluation of glutamate-sensitive radiopharmaceuticals: Technetium-99m-glutamic acid and technetium-99m-diethylenetriaminepentaacetic acid-bis(glutamate) conjugate for tumor imaging.
Topics: Animal Structures; Animals; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Survival; Cysteine; Drug Stability; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Molecular Structure; Neoplasms; Pentetic Acid; Rabbits; Radiopharmaceuticals; Technetium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Whole Body Imaging | 2010 |
Radiolabeling of fab and f(ab')2 antibody fragments with 99mTc(I) tricarbonyl core using a new bifunctional tridentate ligand.
Topics: Cell Line; Chelating Agents; Cysteine; Histidine; Humans; Immunoconjugates; Immunoglobulin Fab Fragments; Isotope Labeling; Ligands; Molecular Structure; Phenols; Radiopharmaceuticals; Receptors, Immunologic; Technetium | 2011 |
Size and specificity of radiopharmaceuticals for sentinel lymph node detection.
Topics: Analysis of Variance; Animals; Cysteine; Dextrans; Female; Lymphatic Metastasis; Mannose; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Technetium | 2011 |
Order of amino acids in C-terminal cysteine-containing peptide-based chelators influences cellular processing and biodistribution of 99mTc-labeled recombinant Affibody molecules.
Topics: Amino Acids; Animals; Chelating Agents; Cysteine; Humans; Isotope Labeling; Mice; Molecular Imaging; Peptides; Receptor, ErbB-2; Recombinant Fusion Proteins; Technetium; Tissue Distribution | 2012 |
Synthesis, characterization and biological evaluation of novel neutral fac-M(CO)3(SNO) complexes (M=Re, 99mTc) bearing the o-methoxyphenylpiperazine moiety.
Topics: Animals; Cysteine; Isotope Labeling; Male; Metabolic Clearance Rate; Organ Specificity; Penicillamine; Propiophenones; Radiopharmaceuticals; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Technetium; Tissue Distribution | 2012 |
Preparation of clinical-scale 99Mo/99mTc column generator using neutron activated low specific activity 99Mo and nanocrystalline γ-Al2O3 as column matrix.
Topics: Aluminum Oxide; Chromatography; Cysteine; Freeze Drying; Molybdenum; Nanoparticles; Neutrons; Radiochemistry; Radioisotopes; Radiopharmaceuticals; Succimer; Technetium | 2012 |
Novel, cysteine-modified chelation strategy for the incorporation of [M(I)(CO)(3)](+) (M = Re, (99m)Tc) in an α-MSH peptide.
Topics: alpha-MSH; Animals; Chelating Agents; Cysteine; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Structure; Organometallic Compounds; Peptides; Radiopharmaceuticals; Rhenium; Technetium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Tumor Cells, Cultured | 2012 |
Formulation and evaluation of a single vial lyophilized preparation of technetium-99m labeled ethylene dicysteine as a renal scintigraphic agent.
Topics: Animals; Chemistry, Pharmaceutical; Cysteine; Freeze Drying; Hydrogen-Ion Concentration; Kidney; Macaca mulatta; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Technetium; Technetium Tc 99m Mertiatide | 2014 |
Patched targeting peptides for imaging and treatment of hedgehog positive breast tumors.
Topics: Amino Acid Sequence; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cysteine; Diagnostic Imaging; Female; Hedgehog Proteins; Humans; Molecular Sequence Data; Molecular Targeted Therapy; Patched Receptors; Patched-1 Receptor; Peptides; Rats, Inbred F344; Receptors, Cell Surface; Spheroids, Cellular; Staining and Labeling; Technetium; Xenograft Model Antitumor Assays | 2014 |
Identification of Staphylococcus aureus infection by aptamers directly radiolabeled with technetium-99m.
Topics: Animals; Aptamers, Nucleotide; Candida albicans; Candidiasis; Cysteine; Drug Stability; Isotope Labeling; Mice; Radionuclide Imaging; Staphylococcal Infections; Staphylococcus aureus; Technetium; Tissue Distribution | 2015 |
Preparation and evaluation of the tumor-specific antigen-derived synthetic mucin 1 peptide: A potential candidate for the targeting of breast carcinoma.
Topics: Amino Acid Sequence; Animals; Breast Neoplasms; Cell Transformation, Neoplastic; Cysteine; Drug Stability; Half-Life; Humans; MCF-7 Cells; Mice; Mucin-1; Peptide Fragments; Protein Transport; Technetium; Tissue Distribution | 2016 |
Influence of composition of cysteine-containing peptide-based chelators on biodistribution of
Topics: Animals; Cell Line, Tumor; Chelating Agents; Cysteine; ErbB Receptors; Humans; Mice; Molecular Imaging; Molecular Probes; Neoplasm Transplantation; Neoplasms; Peptides; Recombinant Fusion Proteins; Technetium; Tissue Distribution | 2018 |
A prospective study evaluating impact on renal function following percutaneous nephrolithotomy using Tc99m ethylenedicysteine renal scan: Does multiplicity of access tracts play a role?
Topics: Adult; Creatinine; Cysteine; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Calculi; Male; Middle Aged; Nephrolithotomy, Percutaneous; Prospective Studies; Radiopharmaceuticals; Technetium; Young Adult | 2019 |
Water-Soluble [Tc(N)(PNP)] Moiety for Room-Temperature
Topics: Cysteine; Organotechnetium Compounds; Radiopharmaceuticals; Technetium; Temperature; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Water | 2022 |
Evaluation of Rhenium and Technetium-99m Complexes Bearing Quinazoline Derivatives as Potential EGFR Agents.
Topics: Animals; Cell Line; Cysteine; ErbB Receptors; Humans; Mice; Quinazolines; Radiopharmaceuticals; Rhenium; Technetium; Tissue Distribution | 2023 |